Beruflich Dokumente
Kultur Dokumente
The idea that if somebody in your family has had cancer you are at increased risk of
getting it because “it‟s in your genes.”
The genetic theory of cancer, also known as „the somatic mutations theory‟, is taught to
doctors and other medical practitioners as if it were fact, but in reality it is just a theory,
meaning it‟s unproven.
Today we‟re going to put this theory to the test to find out once-and-for-all if cancer is
a genetic disease.
Go to
ENDALLDISEASE.COM/ITUNES
• Instead of letting it destroy me, I used the “Don’t fight forces, use them.”
pain inside me as motivation to research ~Buckminster Fuller
and write books on cancer so that no
child would have to go through what I
did, ever again.
Based on the book
This presentation is based on the book Cancer: The Metabolic Disease Unravelled by
Mark Sloan.
The Somatic Mutations Theory of Cancer
- The Mainstream Theory of Cancer - -
The official position of the cancer establishment is that “cancer is a genetic disease,”[1]
whereby a specific set of gene mutations cause a single cell to turn irreversibly cancerous
and multiply out-of-control, until enough of its mutant clones collectively form a tumor
that strives to kill the host.
=
If this theory is correct, it means that cancer cells are like parasites that must be eradicated
at all costs; even if patients are injured or nearly killed in the process.
Weapons of War as Treatments?
It‟s this notion, which I call “the angry cancer cell”, that justifies the use of knives, poison
injections and ionizing radiation on cancer patients.
If it weren‟t for the fear driven into patients by doctors, telling them that they‟re going to die if
they aren‟t rushed into treatment, most people would probably never accept these treatments.
Questioning the genetic theory
• If cancer really is some kind of monster, entirely foreign to the body and living inside us, then we‟re
probably doing the right thing by trying to kill the cells during treatment.
• However, if cancer is not a murderous mutant cell and these treatments are making the health of
patients worse, then we need to know that so we can stop using them. It‟s time to question the
genetic theory of cancer to find out for certain.
• In search of another paradigm that could adequately explain the underlying cause of cancer and
why the war on cancer has been such a failure, I stumbled upon a fascinating series of studies that
completely contradicted the genetic theory of cancer.
Reference 2
(Li L, et al. 2003)
Frog Egg Tumor Transplants
• In 1969, a group of researchers
injected tumor cells from tadpoles
into frog eggs to find out the
condition of the tadpoles that
would emerge from those eggs.
RESULTS:
• From within the eggs emerged healthy,
swimming tadpoles - demonstrating once again
that mutated cancer DNA can direct normal
development.
Reference 3
(McKinnell RG, et al. 1969)
Mutated genetics, normal behavior
The study reports that “The use of a reporter gene in transgenic mice indicates
that there are many local mutations and large genomic rearrangements per
somatic cell that accumulate with age at different rates per organ
and without visible effects.”
Reference 10
(Rubin H. 2006)
Cell Cytoplasm-Swapped „Cybrids‟
• Since the 1970‟s, scientists have been experimenting with swapping normal cell
cytoplasms (containing the energy-producing mitochondria, not DNA) with cancer cell
cytoplasms and vice versa. They call the resultant cells „cybrids.‟
References 4-8
When scientists transplanted normal cell
cytoplasms into cancer cells (containing
mutated DNA), the cancer cells transformed
back into normal cells.
Reference 9
And when cancer cell cytoplasms were
transplanted into normal cells (with normal
DNA), the cells turned into cancer cells.
What these findings show is that mutant cancer DNA does not cause cancer and that
it’s the mitochondria that appears to dictate carcinogenesis.
Solving the controversy
What better way to resolve the controversies
surrounding cancer‟s origins than with the biggest and
most comprehensive scientific investigation ever
conducted on the genetics of cancer?
The Cancer Genome Atlas Project
• In 2005, the National Cancer Institute
launched a giant multi-national initiative
called The Cancer Genome Atlas Project
(TCGAP).
• Dr. David Agus of the University of California, the oncologist who treated Steve Jobs, even
suggested in a recent speech that cancer is simply too difficult to understand and that we
should stop trying. [Reference 24]
The multi-billion dollar Cancer Genome Atlas Project, a fascinating milestone in the history of
cancer research, has taught us many remarkable things about cancer genetics and confirmed
to us unequivocally that, above all,
After the results of TCGAP, the 81-year-old “father of DNA” himself, James Watson,
responded publically by recommending a shift in the focus of cancer research
from genetics to metabolism.
How to Support my work
Handheld device
visit
EndAllDisease.com/store
Bodylight Mini
Full Bodylight
order my books
visit
EndAllDisease.com/books
The Cancer Industry
For the show notes and to sign up to our mailing list, Go to:
EndAllDisease.com/episode11
If you enjoyed this presentation,
please share it with someone you love.
1.
References
The Canadian Cancer Society. What is cancer? [Online]. Available: https://www.Cancer.Gov/about-cancer/understanding/what-is-cancer.
[March 1st, 2017].
2. Li L, connelly MC, wetmore C, curran T, morgan JI. Mouse embryos cloned from brain tumors. Cancer res. 2003;63(11):2733-6.
https://www.ncbi.nlm.nih.gov/pubmed/12782575
3. Mckinnell RG, deggins BA, labat DD. Transplantation of pluripotential nuclei from triploid frog tumors. Science. 1969;165(3891):394-6.
https://www.ncbi.nlm.nih.gov/pubmed/5815255
4. Shay JW, werbin H. Cytoplasmic suppression of tumorigenicity in reconstructed mouse cells. Cancer res. 1988;48(4):830-3.
https://www.ncbi.nlm.nih.gov/pubmed/3123054
5. Israel ba, schaeffer wi. Cytoplasmic suppression of malignancy. In vitro cell dev biol. 1987;23(9):627-32.
https://www.ncbi.nlm.nih.gov/pubmed/3654482
6. Howell an, sager r. Tumorigenicity and its suppression in cybrids of mouse and chinese hamster cell lines. Proc natl acad sci USA.
1978;75(5):2358-62.
https://www.ncbi.nlm.nih.gov/pubmed/276880
7. Shay jw, liu yn, werbin h. Cytoplasmic suppression of tumor progression in reconstituted cells. Somat cell mol genet. 1988;14(4):345-50.
https://www.ncbi.nlm.nih.gov/pubmed/3399962
8. Giguère l, morais r. On suppression of tumorigenicity in hybrid and cybrid mouse cells. Somatic cell genet. 1981;7(4):457-71.
https://www.ncbi.nlm.nih.gov/pubmed/7280931
9. Israel BA, schaeffer WI. Cytoplasmic mediation of malignancy. In vitro cell dev biol. 1988;24(5):487-90.
https://www.ncbi.nlm.nih.gov/pubmed/3372452
10. Rubin H. What keeps cells in tissues behaving normally in the face of myriad mutations?. Bioessays. 2006;28(5):515-24.
https://www.ncbi.nlm.nih.gov/pubmed/16615084
11. Greenman C, stephens P, smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446(7132):153-8.
https://www.ncbi.nlm.nih.gov/pubmed/17344846
14. Salk JJ, fox EJ, loeb LA. Mutational heterogeneity in human cancers: origin and consequences. Annu rev pathol. 2010;5:51-75.
https://www.ncbi.nlm.nih.gov/pubmed/19743960
15. Gibbs WW. Untangling the roots of cancer. Sci am. 2003;289(1):56-65.
https://www.ncbi.nlm.nih.gov/pubmed/12840947
16. Steeg ps. Heterogeneity of drug target expression among metastatic lesions: lessons from a breast cancer autopsy program. Clin cancer res. 2008;14(12):3643-
5.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692037
17. Wu jm, fackler mj, halushka mk, et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation
between primary tumors and their multifocal metastases. Clin cancer res. 2008;14(7):1938-46.
https://www.ncbi.nlm.nih.gov/pubmed/18381931
18. Gabor miklos gl. The human cancer genome project--one more misstep in the war on cancer. Nat biotechnol. 2005;23(5):535-7.
https://www.nature.com/articles/nbt0505-535
19. Seyfried TN, shelton LM. Cancer as a metabolic disease. Nutr metab (lond). 2010;7:7.
https://www.ncbi.nlm.nih.gov/pubmed/20181022
21. Mandinova a, lee sw. The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci transl med. 2011;3(64):64rv1.
https://www.ncbi.nlm.nih.gov/pubmed/21209413
22. Gravendeel la, kouwenhoven mc, gevaert o, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer res.
2009;69(23):9065-72.
https://www.ncbi.nlm.nih.gov/pubmed/19920198
23. Dang l, white dw, gross s, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739-44.
https://www.ncbi.nlm.nih.gov/pubmed/19935646
24. Agus, D. [Ted]. (2010). David agus: A new strategy in the war against cancer. Available: https://www.Youtube.Com/watch?V=irxgdmsp9gs.[March 1, 2017].